We aimed to identify the donor or recipient origin of autoimmune thyroid disease in a boy who underwent bone marrow transplantation (BMT) for severe aplastic anemia from his HLA-matched sister, who had been diagnosed with Graves disease 5 years before transplantation. After 2 years of BMT, the same disease was diagnosed in the recipient. Thyroidectomy was performed after achieving a euthyroid state. The thyroid gland contained interstitial lymphocytic infiltrates. Fluorescence in situ hybridization (FISH) analysis showed that at least some of the lymphocytes were of donor origin and these could be seen among the recipient's thyroid cells.
Endocrine dysfunction affecting the thyroid gland, growth and gonad function are the most common longterm adverse effects of BMT. 1 Autoimmune Graves disease is a rare event after HSCT and when it does occur, it raises the question as to whether it has been transferred from the donor or whether it is a result of disturbances in immune reconstitution and immune function due to severe immunosuppression. In our study, we aimed to ascertain the donor or recipient origin of autoimmune thyroid disease in a boy who underwent BMT for severe aplastic anemia from his HLA-matched sister, who had been diagnosed with Graves disease 5 years before the transplant.
A 14-year-old boy was diagnosed with severe aplastic anemia in 2000. His 21-year-old sister had been identified as a matched related donor. She had been treated for Graves disease and had undergone resection of the thyroid gland 5 years earlier. However, at the time of bone marrow donation, she did not require treatment and was therefore considered to be a healthy donor.
Conditioning consisted of ATG (rabbit) total dose 25 mg/kg bw and cyclophosphamide 200 mg/kg bw. A total of 3 Â 10 8 /kg bw donor nuclear cells were given. The GvHD prophylaxis consisted of cyclosporine A and short-course methotrexate. Engraftment occurred, although hematological recovery was slow. No signs of acute GvHD, severe toxicity or infections were observed. The patient was discharged on day þ 44 post transplantation. Immunosuppression was gradually tapered from day þ 180 and discontinued on day þ 220. The patient did not require readmission to hospital and was followed up as an outpatient. After stem cell transplantation, the patient's immune reconstitution and peripheral blood chimerism were examined. His chimerism status was regularly checked during the post transplant period. Results are shown in Table 1 . Stable mixed chimerism was present from 6 months post transplant and remained until the last followup. At 12 months after transplant, the number of CD3/ CD4 lymphocytes reached 200/ml, and normalization of CD4/CD8 (helper/suppressor) ratio was observed.
Two years after transplantation, the patient started to lose weight and suffered from sleep disturbances. Clinically he presented with tachycardia (160/min), and grade II goiter. He was referred to the endocrinology department and Graves disease was confirmed as the cause of hyperthyroidism. Laboratory results were as follows: TSH -0.041 mIU/ml (normal range 0.35-4.6), serum free T4 -5.62 ng/dl (normal range 0.71-1.85), TT3 -5.13 ng/ml (normal range 0.45-2), anti-thyroid peroxidase (TPO) antibody level 412 IU/ml (normal range up to 34), antithyroglobulin antibody (TG) level 200 IU/ml (normal range up to 12) and anti-TSH-receptor antibody (TRAB) level 38.64 IU/ml (normal range up to 2). The patient was treated with lithium carbonicum and thiamazole and underwent an uneventful thyroidectomy after becoming euthyroid. Two years after surgery and five years after transplantation, he is stably euthyroid with satisfactory and stable hematopoiesis.
The thyroid gland tissue removed during surgery was routinely fixed in 10% buffered formalin and embedded in paraffin. Histopathologic sections stained with hematoxylin and eosin showed interstitial lymphocytic infiltrates and follicles containing scanty amounts of colloid and some pleomorphic nuclei by microscopy ( Figure 1 ).
Fluorescence in situ hybridization studies were performed on the formalin-fixed, paraffin-embedded tissue cut into 4 mm thick sections and applied to silanized slides. Fluorescence in situ hybridization was performed using a commercially available CEP X/Y DNA Probe (Vysis), which is a combination of a SpectrumOrange-labeled CEP probe for the alpha satellite centromeric region of chromosome X and a SpectrumGreen-labeled CEPY probe specific for the satellite III region. Slides were evaluated with an epifluorescence microscope equipped with a 100 Â oil immersion objective and appropriate set of filters. Images were captured with a Cytovision Imaging System, version 2.7 (Applied Imaging, UK). The FISH results indicated that at least some of the lymphocytes infiltrating the thyroid gland were of donor origin, and these could be seen among the recipient's thyroid cells (Figure 2) .
The transfer of donor immunocompetent cells to the recipient of hematopoetic stem cells has been proposed as a mechanism of inducing autoimmune thyroiditis post transplantation. Donor and recipient were matched at HLA antigen classes I and II (6/6) and shared the antigens B8 and DRb1*03, considered to be a genetic marker of Graves disease. 2 Lymphocyte depletion using CD34 þ selection of the graft does not prevent disease occurrence. [3] [4] [5] The same mechanism can be postulated with regard to the development of donor immunity in a host with Graves disease before transplantation, which resolved post transplant. 6 However, there are reports that confirm that autoimmune thyroiditis may recur after successful stem cell transplantation 7 or that it can occur for the first time in the post transplant period. 8 Immune dysfunction after transplantation, and immunosuppression given as prophylaxis and treatment of GvHD may promote development of an autoimmune disease, which has either been transferred from the donor or developed de novo in susceptible individuals. 9 In conclusion, one can speculate that the Graves disease related to the patient's genetic predisposition, especially as mixed chimerism was present throughout the observation time. Our study provides evidence that after stem cell transplantation, lymphocytes of donor origin can infiltrate the thyroid gland and are presumably able to trigger the autoimmune processes affecting this tissue. Our finding emphasizes the importance of careful monitoring for longterm effects after HSCT. 6  55  45  124  35  153  306  12  53  47  181  204  174  212  24  51  49  199  279  180  203  30  58  42  234  507  207  251  42  56  44  269  468  198  269 Abbreviations: BMT ¼ bone marrow transplantation; FISH ¼ fluorescence in situ hybridization. Letter to the Editor
